# Riluzole in Patients With Spinocerebellar Ataxia Type 7

> **NCT03660917** · PHASE2,PHASE3 · RECRUITING · sponsor: **S. Andrea Hospital** · enrollment: 34 (estimated)

## Conditions studied

- SCA7

## Interventions

- **DRUG:** Riluzole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03660917
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660917, "Riluzole in Patients With Spinocerebellar Ataxia Type 7". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03660917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*